I. Department of Medicine, Section of Infectious Diseases, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Institute of Virology, Medical Faculty, University Hospital Düsseldorf, Heinrich-Heine-Universität, Düsseldorf, Germany.
Front Immunol. 2022 Jun 6;13:886646. doi: 10.3389/fimmu.2022.886646. eCollection 2022.
Thymocyte selection-associated high mobility group box (TOX) has been described to be a key regulator in the formation of CD8+ T cell exhaustion. Hepatitis C virus (HCV) infection with different lengths of antigen exposure in acute, chronic, and after resolution of HCV infection is the ideal immunological model to study the expression of TOX in HCV-specific CD8+ T cells with different exposure to antigen. HCV-specific CD8+ T cells from 35 HLA-A01:01, HLA-A02:01, and HLA-A*24:02 positive patients were analyzed with a 16-color FACS-panel evaluating the surface expression of lineage markers (CD3, CD8), ectoenzymes (CD39, CD73), markers of differentiation (CD45RO, CCR7, CD127), and markers of exhaustion and activation (TIGIT, PD-1, KLRG1, CD226) and transcription factors (TOX, Eomesodermin, T-bet). Here, we defined on-target T cells as T cells against epitopes without escape mutations and off-target T cells as those against a "historical" antigen mutated in the autologous sequence. TOX+HCV-specific CD8+ T cells from patients with chronic HCV and on-target T cells displayed co-expression of Eomesodermin and were associated with the formation of terminally exhausted CD127PD1, CD39, CD73 CD8+ T cells. In contrast, TOX+HCV-specific CD8+ T cells in patients with off-target T cells represented a progenitor memory Tex phenotype characterized by CD127 expression and a CD39 and CD73 phenotype. TOX+HCV-specified CD8+ T cells in patients with a sustained virologic response were characterized by a memory phenotype (CD127+, CD73) and co-expression of immune checkpoints and Eomesodermin, indicating a key structure in priming of HCV-specific CD8+ T cells in the chronic stage, which persisted as a residual after therapy. Overall, the occurrence of TOX+HCV-specific CD8+ T cells was revealed at each disease stage, which impacted the development of progenitor Tex, intermediate Tex, and terminally exhausted T cell through an individual molecular footprint. In sum, TOX is induced early during acute infection but is modulated by changes in viral sequence and antigen recognition. In the case of antigen persistence, the interaction with Eomesodermin leads to the formation of terminally exhausted virus-specific CD8+ T cells, and there was a direct correlation of the co-expression of TOX and Eomes and terminally exhausted phenotype of virus-specific CD8+ T cells.
胸腺细胞选择相关高迁移率族框(TOX)已被描述为形成 CD8+T 细胞耗竭的关键调节因子。丙型肝炎病毒(HCV)感染具有急性、慢性和 HCV 感染后消退期间不同长度的抗原暴露,是研究不同抗原暴露的 HCV 特异性 CD8+T 细胞中 TOX 表达的理想免疫模型。使用评估谱系标志物(CD3、CD8)、外切酶(CD39、CD73)、分化标志物(CD45RO、CCR7、CD127)、耗竭和激活标志物(TIGIT、PD-1、KLRG1、CD226)和转录因子(TOX、Eomesodermin、T-bet)的 16 色 FACS 面板分析了来自 35 名 HLA-A01:01、HLA-A02:01 和 HLA-A*24:02 阳性患者的 HCV 特异性 CD8+T 细胞。在这里,我们将针对靶标 T 细胞定义为针对无逃逸突变的表位的 T 细胞,将针对自体序列中发生突变的“历史”抗原的非靶标 T 细胞定义为针对靶标 T 细胞。慢性 HCV 患者中的 TOX+HCV 特异性 CD8+T 细胞和针对靶标 T 细胞表现出 Eomesodermin 的共表达,并与终末耗尽的 CD127PD1、CD39、CD73 CD8+T 细胞的形成相关。相比之下,针对靶标 T 细胞的 TOX+HCV 特异性 CD8+T 细胞代表了特征为 CD127 表达和 CD39 和 CD73 表型的祖细胞记忆 Tex 表型。具有持续病毒学应答的患者中的 TOX+HCV 特异性 CD8+T 细胞表现出记忆表型(CD127+,CD73+)和免疫检查点和 Eomesodermin 的共表达,表明 HCV 特异性 CD8+T 细胞在慢性阶段的启动中具有关键结构,该结构在治疗后作为残留存在。总体而言,TOX 在每个疾病阶段都被揭示出来,它通过个体分子特征影响祖细胞 Tex、中间 Tex 和终末耗尽 T 细胞的发展。总之,TOX 在急性感染早期被诱导,但会被病毒序列和抗原识别的变化所调节。在抗原持续存在的情况下,与 Eomesodermin 的相互作用导致终末耗尽的病毒特异性 CD8+T 细胞的形成,并且 TOX 和 Eomes 的共表达与病毒特异性 CD8+T 细胞的终末耗尽表型之间存在直接相关性。